Physical Activity in De Novo Parkinson Disease: Daily Step Recommendation and Effects of Treadmill Exercise on Physical Activity

Handlery, Reed; Stewart, Jill Campbell; Pellegrini, Christine A.; Monroe, Courtney M.; Hainline, Garrett; Flach, Alicia; Handlery, Kaci; Fritz, Stacy L.

doi:10.1093/ptj/pzab174

Cited by 9 publications

(16 citation statements)

References 62 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The objective of the 26 studies ranged from observational (n = 18, 69.2%) [19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36] to interventional studies (n = 6, 23.1%) [37][38][39][40][41][42] including pre-and post-measurements or the comparison of walking activity parameters with a control group. Two studies can be considered as proof of concept [28,43].…”

Section: Study Characteristicsmentioning

confidence: 99%

“…Among all participants, 584 females and 679 males were included in this review. Disease severity was assessed using Hoehn and Yahr (n = 20, 76.9%) [19,20,[22][23][24][26][27][28][29][30][31][33][34][35][36][37][38]41,42,44] and MDS-UPDRS Part III (n = 18, 69.2%) [19,20,22,[24][25][26][27]29,31,32,[34][35][36][37][38][39]41,42]. If reported, disease duration ranged from 0.8 [37] to 12.5 years [30] (Table A2).…”

Section: Sample Characteristicsmentioning

confidence: 99%

“…The most frequently used wearable device was the AGT3X [19][20][21][22][23][36][37][38][39][40] used in 10 studies (38.5%). StepWatch Activity Monitors (SAM) were used in seven studies (26.9%): the StepWatch (n = 3, 11.5%) [24,25,43], the StepWatch 3 (n = 3, 11.5%) [26,27,41], and the StepWatch 4 (n = 1, 3.8%) [28].…”

Section: Type Of Sensorsmentioning

confidence: 99%

“…Figure 4 illustrates proportion of sensors. The most commonly used sensors were triaxial accelerometers (n = 16, 61.5%) [19][20][21][22][23][31][32][33][34][35][36][37][38][39][40]42], followed by microprocessor linked devices which were used in seven studies (26.9%) [24][25][26][27][28]41,43]. Furthermore, two (7.7%) studies conducted assessments with uniaxial accelerometers [29,30].…”

Section: Type Of Sensorsmentioning

confidence: 99%

“…Figure 5 allows a better understanding of the outcomes measured. Sedentary behavior was explored in 11 studies (42.3%) [19,21,23,26,[31][32][33][34][35]39,40], and measured in min•day −1 or in min•hours −1 of wear time. Finally, active time is an outcome of interest due to the important number of articles which evaluated active time (n = 21, 80.8%) [19][20][21][22][23][24]26,27,[29][30][31][32][33][34][35][36][37]39,40,42,44].…”

Section: Outcomes Of Interestmentioning

confidence: 99%

See 4 more Smart Citations

Objective Measurement of Walking Activity Using Wearable Technologies in People with Parkinson Disease: A Systematic Review

Correno

Hansen

Carlin

et al. 2022

Sensors

View full text Add to dashboard Cite

Parkinson’s disease (PD) is a complex neurodegenerative disease with a multitude of disease variations including motor and non-motor symptoms. Quality of life and symptom management may be improved with physical activity. Due to technological advancement, development of small new wearable devices recently emerged and allowed objective measurement of walking activity in daily life. This review was specifically designed to synthesize literature on objective walking activity measurements using wearable devices of patients with PD. Inclusion criteria included patients with a diagnosis of PD and exclusion criteria included studies using animal models or mixed syndromes. Participants were not required to undergo any type of intervention and the studies must have reported at least one output that quantifies daily walking activity. Three databases were systematically searched with no limitation on publication date. Twenty-six studies were eligible and included in the systematic review. The most frequently used device was the ActiGraph GT3X which was used in 10 studies. Duration of monitoring presented a range from 8 h to one year. Nevertheless, 11 studies measured walking activity during a 7-day period. On-body sensor wearing location differed throughout the included studies showing eight positions, with the waist, ankle, and wrist being the most frequently used locations. The main procedures consisted of measurement of walking hours during a 2-day period or more, equipped with a triaxial accelerometer at the dominant hip or ankle. It is also important for further research to take care of different factors such as the population, their pathology, the period, and the environment.

show abstract

Section: Study Characteristicsmentioning

confidence: 99%

Section: Sample Characteristicsmentioning

confidence: 99%

Section: Type Of Sensorsmentioning

confidence: 99%

Section: Type Of Sensorsmentioning

confidence: 99%

Section: Outcomes Of Interestmentioning

confidence: 99%

See 3 more Smart Citations

Objective Measurement of Walking Activity Using Wearable Technologies in People with Parkinson Disease: A Systematic Review

Correno

Hansen

Carlin

et al. 2022

Sensors

View full text Add to dashboard Cite

show abstract

Updates in Parkinson’s Disease Integrative Therapies: an Evidence-Based Review

Kola,

Subramanian

2023

Curr Neurol Neurosci Rep

View full text Add to dashboard Cite

Exercise for People with Parkinson’s Disease: Updates and Future Considerations

MCGINLEY,

NAKAYAMA

2024

Phys Ther Res

View full text Add to dashboard Cite

Parkinson's disease (PD) is now the world's fastest-growing neurological disorder with rapidly rising prevalence and increasing demand for effective health services. Recent research has focused on the importance of early diagnosis and proactive management of physical function. Accumulating evidence indicates that reduced physical activity levels and mild pre-clinical disability are present in many people prior to a clinical diagnosis, perhaps developing over years. Early referral to a physiotherapist at the time of diagnosis is now recommended in global guidelines. Multiple forms of exercise have been found to have benefits in early and mid-stage disease across a range of motor and non-motor symptoms. Evidence from longitudinal studies confirms that disability is delayed when regular exercise is sustained over long periods. Exercise is now recognized as an essential component of treatment, in combination with medical therapies. Contemporary physiotherapy interventions now combine health behavior change techniques with physical exercise to promote the development of long-term exercise adherence. Advances in technology and digital health have progressed quickly and now offer opportunities for remote assessment and monitoring, remote exercise supervision, and support adherence through feedback and motivational strategies. Recent biomedical discoveries forecast improved earlier and more accurate diagnosis of PD, allowing opportunities for earlier interventions. Current research in progress will provide important insights into the dose and intensity of aerobic exercise in PD. Physiotherapists have important roles in advocacy and education in conjunction with care delivery to support access to evidence-based care for all people with PD.

show abstract

Physical Activity in De Novo Parkinson Disease: Daily Step Recommendation and Effects of Treadmill Exercise on Physical Activity

Cited by 9 publications

References 62 publications

Objective Measurement of Walking Activity Using Wearable Technologies in People with Parkinson Disease: A Systematic Review

Objective Measurement of Walking Activity Using Wearable Technologies in People with Parkinson Disease: A Systematic Review

Updates in Parkinson’s Disease Integrative Therapies: an Evidence-Based Review

Exercise for People with Parkinson’s Disease: Updates and Future Considerations

Contact Info

Product

Resources

About